Chronic discoid lupus erythematosus in Thailand: Direct immunofluorescence study

International Journal of Dermatology

Volumn 35, Issue 10, 1996, Pages 711-714

  Kulthanan, Kanokvalai ^a   Roongphiboolsopit, Paisal ^b   Chanjanakijskul, Somchai ^b   Kullavanijaya, Preya ^b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISCOID LUPUS ERYTHEMATOSUS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; MALE; THAILAND;

EID: 0029966903     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-4362.1996.tb00643.x     Document Type: Article

References (17)

1. Williams REA, Mackie RM, O'Keefe R, Thomson W. The contribution of direct immunofluorescence to the diagnosis of lupus erythematosus. J Cutan Pathol 1989; 16:122-125.
2. Tuffanelli DL. Cutaneous immunopathology: recent observations. J Invest Dermatol 1975; 65:143-153.
3. Prystowsky SD, Herndon JH, Gilliam JN. Chronic cutaneous lupus erythematosus (DLE): a clinical and laboratory investigation of 80 patients. Medicine 1975; 55: 183-191.
4. Boey ML, Peebles CL, Tsay G, et al. Clinical and autoantibody correlation in orientals with systemic lupus erythematosus. Ann Rheum Dis 1988; 47:918-923.
5. Nishikawa T, Provost TT. Difference in clinical, serologic and immunogenetic features of white versus oriental anti-SS-A/Ro positive patients. J Am Acad Dermatol 1991; 25:563-564.
6. Beutner EH, Kumar V, Krasny DA, et al. Defined immunofluorescence immunodermatology. In: Beutner EH, Chorzelski TP, Kumar V, eds. Immunopathology of the skin. 3rd Ed. New York: John Wiley & Son, 1987:3-40.
7. Beutner EH, Jordon RE, Chorzelski TP. The immunopathology of pemphigus and bullous pemphigoid. J Invest Dermatol 1968; 51:63-80.
8. Valenzuela R, Bergfeld WF, Deodhar SD. Interpretation of immunofluorescent patterns in skin diseases. Chicago: American Society of Clinical Pathologists Press, 1984: 22-24.
9. Cripps DJ, Rankin J. Action spectra of lupus erythematosus and experimental immunofluorescence. Arch Dermatol 1973; 107:563-567.
10. Jablonska S, Chorzelski TP, Beutner EH. Indications for skin and serum immunofluorescence in dermatology. In: Beutner EH, Chorzelski TP, Bean SF, eds. Immunopathology of the skin. New York: John Wiley & Son, 1979:16-17.
11. Dahl MV. Usefulness of direct immunofluorescence in patients with lupus erythematosus. Arch Dermatol 1983; 119:1010-1017.
12. Tuffanelli DL, Kay D, Fukuyama K. Dermal-epidermal junction in lupus erythematosus. Arch Dermatol 1969; 99:652-662.
13. Ueki H. Hyaline bodies in subepidermal papillae. Arch Dermatol 1969; 100:610-617.
14. Gogate P, Valenzuela R, Deodhar SD, et al. Globular deposits of immunoglobulins and complement in the papillary dermis: clinical significance. J Clin Pathol 1980; 73:512-517.
15. Faille-Kuyp B, Cormane RH. The occurrence of certain serum factors in the dermo-epidermal junction and vessel walls of the skin in lupus erythematosus and other (skin) diseases. Acta Derm Venereol (Stockh) 1968; 48: 578-587.
16. Burrows NP, Bhogal BS, Russell Jones R, Black MM. Clinicopathological significance of cutaneous epidermal nuclear staining by direct immunofluorescence. J Cutan Pathol 1993; 20:159-162.
17. Velthuis PJ, Kater L, Van der Tweel I, et al. In vivo antinuclear antibody of the skin: diagnostic significance and association with selective antinuclear antibodies. J Rheum Dis 1990; 49:163-167.